Achieve Life Sciences Inc.

9.77-0.4600-4.50%Vol 75.62K1Y Perf 45.90%
Apr 16th, 2021 11:13 DELAYED
BID9.79 ASK9.89
Open10.35 Previous Close10.23
Pre-Market- After-Market-
 - -%  - -
Target Price
45.00 
Analyst Rating
Strong Buy 1.00
Potential %
355.93 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap60.09M 
Earnings Rating
Neutral
Price Range Ratio 52W %
27.19 
Earnings Date
13th May 2021

Today's Price Range

9.6410.49

52W Range

6.6018.26

5 Year PE Ratio Range

-0.5000-0.4000

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-10.26%
1 Month
-12.49%
3 Months
4.92%
6 Months
14.94%
1 Year
45.90%
3 Years
-96.13%
5 Years
-99.45%
10 Years
-99.97%

TickerPriceChg.Chg.%
ACHV9.77-0.4600-4.50
AAPL133.82-0.6800-0.51
GOOG2 295.90-0.7600-0.03
MSFT259.28-0.2200-0.08
XOM56.97-0.0100-0.02
WFC43.150.91002.15
JNJ160.960.57000.36
FB305.77-2.0500-0.67
GE13.45-0.1000-0.74
JPM153.311.14000.75
Earnings HistoryEstimateReportedSurprise %
Q04 2020-1.27-1.1112.60
Q03 2020-1.30-1.1412.31
Q02 2020-3.80-1.6855.79
Q01 2020--2.20-
Q04 2019-5.40-6.00-11.11
Q03 2019-4.40-9.00-104.55
Q02 2019-6.60-10.00-51.52
Q01 2019--17.60-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.7885.39Positive
6/2021 QR-0.8479.36Positive
12/2021 FY-4.61--
12/2022 FY-3.20--
Next Report Date13th May 2021
Estimated EPS Next Report-0.78
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume75.62K
Shares Outstanding6.15M
Trades Count721
Dollar Volume3.09M
Avg. Volume259.01K
Avg. Weekly Volume72.21K
Avg. Monthly Volume61.41K
Avg. Quarterly Volume268.32K

Achieve Life Sciences Inc. (NASDAQ: ACHV) stock closed at 10.23 per share at the end of the most recent trading day (a -2.48% change compared to the prior day closing price) with a volume of 61.42K shares and market capitalization of 60.09M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 14 people. Achieve Life Sciences Inc. CEO is John Bencich.

The one-year performance of Achieve Life Sciences Inc. stock is 45.9%, while year-to-date (YTD) performance is 26.3%. ACHV stock has a five-year performance of -99.45%. Its 52-week range is between 6.6 and 18.26, which gives ACHV stock a 52-week price range ratio of 27.19%

Achieve Life Sciences Inc. currently has a PE ratio of -1.90, a price-to-book (PB) ratio of 1.86, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -46.58%, a ROC of -77.06% and a ROE of -51.74%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Achieve Life Sciences Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.78 for the next earnings report. Achieve Life Sciences Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for Achieve Life Sciences Inc. is Strong Buy (1), with a target price of $45, which is +355.93% compared to the current price. The earnings rating for Achieve Life Sciences Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Achieve Life Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Achieve Life Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.33, ATR14 : 1.09, CCI20 : -160.31, Chaikin Money Flow : -0.12, MACD : -0.50, Money Flow Index : 30.06, ROC : -8.66, RSI : 40.29, STOCH (14,3) : 7.83, STOCH RSI : 0.16, UO : 33.96, Williams %R : -92.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Achieve Life Sciences Inc. in the last 12-months were: Cindy Jacobs (Option Excercise at a value of $0), John Bencich (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.

CEO: John Bencich

Telephone: +1 425 686-1500

Address: 520 Pike Street, Seattle 98101, WA, US

Number of employees: 14

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

63%38%

Bearish Bullish

46%54%

Bearish Bullish

56%44%

News

Stocktwits